How a third culture kid found her place as a medical student in the US – Study International News

Even before she knew it, Christie Zhengs experience in an international high school was preparing her for US medical school. Born in New Zealand and raised in China, her international education exposed her to a diverse learning environment: students came from various cultural backgrounds, and the curricula encourage students to explore their passion.

I also had ample opportunities to travel with friends abroad to participate in swimming and business competitions, the University of Virginia medical student tells over e-mail. Fuelled by her love for food, travel, and learning, Zheng was compelled to continue her education abroad. Her decision was sealed when she got accepted by a university close to her heart.

Now, having settled in Virginia, Zheng mentors other international students applying for medical school in the US via F-1 Doctors. Heres what she has to say about her experience so far.

Zheng intends to apply for residency programmes in the US upon completing her course. Source: Christie Zheng

I chose to be a medical student in the US because of the high-quality medical training and cutting-edge research. I am currently studying at the University of Virginia in Charlottesville. What attracted me, in the beginning, was the programme itself, but over time, I have also grown to enjoy living in the city. Public transportation is really convenient in Charlottesville and there are many amazing local restaurants to try out as well.

I am currently studying medicine at the University of Virginia. I chose this programme because of the integrated curriculum and the welcoming learning environment. The curriculum at UVA provides us with very early patient exposures and encourages us to think about different perspectives of medicine, including ethics, quality improvement, and social issues. Faculty members I have met are more than happy to provide us with support, which extends beyond the classroom to shadowing and research. We are also proud of the collaborative environment among the student body.

The most memorable time for me was probably spending Chinese New Year with a bunch of friends. We made dumplings from scratch and the master baker of our group also made delicious egg tarts. Nothing is better than celebrating a traditional holiday with close friends and tasty food!

Since there are lots of amazing programmes here, I advise all future medical students in the US to do thorough research on the programmes to gain a better idea of which one fits the best. Some relevant topics include the specific curriculum of the programme, financial aid availability for international students, and location.

I am super excited for the upcoming clinical years and I am planning to apply to residency programmes after completing medical school.

Link:
How a third culture kid found her place as a medical student in the US - Study International News

Fauci reacts to Bannon: ‘That’s not the kind of thing you think about’ at medical school | TheHill – The Hill

DAnthony FauciAnthony FauciOvernight Health Care: COVID-19 cases rising in every state | Wisconsin health official warns state nearing 'tipping point' | Fauci predicts data from Moderna vaccine within a week Fauci reacts to Bannon: 'That's not the kind of thing you think about' at medical school Fauci predicts data from Moderna COVID-19 vaccine within a week MORE, the nation's top infectious diseases specialist, said formerTrump adviser Stephen Bannon calling for his beheading isnot the kind of thing you think about when you're going through medical school.

Bannoncaused outragelast week when he said that he wanted to put Fauci and FBI Director Christopher Wrays heads on pikes.

Fauci was asked on the Australian TV news program "The 7:30 Report" what it was like managing a pandemic and dealing with Donald Trump at the same time.

Well, it's obviously been very stressful, Fauci responded in an interview published Wednesday. To deny that would be to deny reality, when you have public figures like Bannon calling for your beheading, that's really kind of unusual, I think. That's not the kind of thing you think about when you're going through medical school to be a physician. But I've gotten through it by really focusing like a laser beam on exactly what my goal is.

President TrumpDonald John TrumpState Department won't give Biden messages from foreign leaders: report Arizona's GOP AG says people voted Republican, but not for Trump On The Money: Biden wins America's economic engines | Progressives praise Biden's picks for economic transition team | Restaurants go seasonal with winter shutdowns during pandemic MORE himself has also suggested he might fire Fauci, who said he is trying to focus on developing vaccines and treatments and encouraging Americans to take public health precautions like wearing masks and maintaining distance from others.

If you focus on that and don't get distracted by all the other noise, then it's not as bad as you might think it is. It's when you start to focus on that other junk as I call it, it's noise. It's meaningless. People calling for you to be beheaded, fired, thrown in the fire pit or whatever, that's just noise, he said.

He also said lockdowns should be a last resort and instead is focused on getting more Americans to take precautions like wearing a mask.

Fauci indicated he has not been in touch with President-elect Joe BidenJoe BidenBrewery launches new Biden beer described as 'inoffensive and not too bitter' Deb Haaland says 'of course' she would serve as Interior secretary under Biden State Department won't give Biden messages from foreign leaders: report MOREs transition team, as Trump has not conceded the race and his administration has not taken steps to begin the transition process, including on the coronavirus response.

Right now, the situation, as you well know, is a rather tense situation in the United States regarding transitions, so right now things are on hold for the time being, Fauci said.

Asked about the performance of the World Health Organization, which has come under fierce criticism from Trump, Fauci said in the future it should respond in a timely manner without any indication of worrying about political ramifications.

We need countries like China to allow other scientists and health officials to look around and see what's going on, he added. That would be helpful. They did not allow that in the beginning. They essentially did not allow travel to Wuhan. Thats not a good thing.

Here is the original post:
Fauci reacts to Bannon: 'That's not the kind of thing you think about' at medical school | TheHill - The Hill

Want to study medicine in the US? Let F-1 Doctors guide you – Study International News

Medical school is no easy feat, especially when youre studying in a foreign country. So when Azan Zahir Virji, Benjamin Andres Gallo Marin, and Ghazal Aghagoli connected online over this shared struggle, they knew they had to play a part in easing it for others. Thats how F-1 Doctors came to be.

This student-led organisation is a free mentorship initiative for international applicants of the medical degree (MD), Doctor of Dental Medicine (DMD), or residency programmes in the US. Pre-meds can access mentorship and guidance from reliable resources with ease online. Co-founder Virji, a Tanzanian student at Harvard Medical School, shares via e-mail that F-1 Doctors has come a long way in a short time it now has 90 mentors from over 30 countries and has helped over 200 students collectively.

Harvard student Azan Virji from Tanzania is one of the founders of F-1 Doctors, which offers free mentorship and advice for international students who want to get into medical school in the US. Source: Azan Virji

Marin, a Brown University student from Nicaragua, attributes this to the fact that the mentorship programme is simple, fast, and highly effective. A student is able to select the mentor that they wish to speak to by scrolling through the mentor profiles, reading their biographies, and filling an electronic form specific to a given mentor. Next, the mentor is notified via email that a student would like to speak with them. If a mentor determines that they have availability to provide mentorship, they proceed to contact the student directly via email to select a time to meet that is mutually convenient, he explains.

Earnestly enough, international students who approach F-1 Doctors are mostly looking for words of encouragement from those who have successfully gotten into medical school, dental school, or a residency programme. Others are looking for structured advice on how to improve their competitiveness for admission; for example, should they pursue a post-baccalaureate programme or go to graduate school? Then theres the question of funding: what scholarships or bursaries are international students eligible for, if any?

Every student has unique needs that only their specific chosen mentor can address. There are international students at many different stages of their journey college, taking gap years, working, pursuing graduate school, evaluating options and as such having diversity in experiences from our mentors has been key to ensure that each person seeking mentorship can have their questions answered and receive the specific guidance that they need, Marin explains.

Benjamin Andres Gallo Marin, Brown student from Nicaragua, believes there is a mentor for every type of student at F-1 Doctors. Source: Benjamin Andres Gallo Marin

Getting admissions advice from those who have been accepted is a no-brainer. Not only have the mentors of F-1 Doctors navigated the same path you want to take, but with the headstart, theyve also fleshed out tips and perspectives on the application process. Besides one-on-one mentorship, you can also learn from the webinars this organisation hosts.

In our experience, the only challenge that comes with being an international applicant is the limited number of schools you can apply to, Virji shares. Only 49 of the 141 medical schools in the country accept non-US citizens. Since most of these schools happen to be the top schools in the country, the application process is competitive for international applicants.

On the bright side, the widely-perpetuated idea that US health programmes do not offer financial aid is not entirely true. While many schools do require non-US citizens to take out loans and show proof of funding for four years of school, others offer students financial help either in the form of institutional loans (low-interest rate and deferred payment) or scholarships (merit-based or need-based). To demonstrate which schools do this, we created an online Excel document with a list of all medical schools international applicants can apply to and their respective financial aid policies, Virji says.

F-1 Doctors is based in Brown University, where its very first chapter was recognised at The Warren Alpert Medical School of Brown University. This is also the main source of the organisations funding.

Its main commodity may be the mentors spread across medical schools in the US, but F-1 Doctors has also established partnerships with other organisations that share its mission. This includes Prescribe it Forward, a newly formed mentorship group for students applying to US medical school, and Uplift, an organisation that creates a guide for first-generation, low-income students applying to US medical schools. On social media, F-1 Doctors spread the message of their work through collaborations with Just Moved to Yankee and Africa International Circle.

If you are a medical student, mentoring is a great way to give back during these restricted times. Many of us have truly seen the role mentorship has played in our careers. Being a mentor at F-1 Doctors not only allows you to be a part of our community but also provides you with an opportunity to make an impact in the lives of international students who also wish to attend health professional programs in the US, Virji shares.

He adds, Immigrant physicians make up almost 28% of all physicians and 24% of all dentists in the US. The last few months however have been quite challenging for international students when it comes to immigration. Moving forward, we aspire to see a future where international students can pursue their American Dream and find all the support they need to enrol at health professional programmes across the country.

Here is the original post:
Want to study medicine in the US? Let F-1 Doctors guide you - Study International News

Risks and benefits of an AI revolution in medicine – Harvard Gazette

If you start applying it, and its wrong, and we have no ability to see that its wrong and to fix it, you can cause more harm than good, Jha said. The more confident we get in technology, the more important it is to understand when humans can override these things. I think the Boeing 737 Max example is a classic example. The system said the plane is going up, and the pilots saw it was going down but couldnt override it.

Jha said a similar scenario could play out in the developing world should, for example, a community health worker see something that makes him or her disagree with a recommendation made by a big-name companys AI-driven app. In such a situation, being able to understand how the apps decision was made and how to override it is essential.

If you see a frontline community health worker in India disagree with a tool developed by a big company in Silicon Valley, Silicon Valley is going to win, Jha said. And thats potentially a dangerous thing.

Researchers at SEAS and MGHs Radiology Laboratory of Medical Imaging and Computation are at work on the two problems. The AI-based diagnostic system to detect intracranial hemorrhages unveiled in December 2019 was designed to be trained on hundreds, rather than thousands, of CT scans. The more manageable number makes it easier to ensure the data is of high quality, according to Hyunkwang Lee, a SEAS doctoral student who worked on the project with colleagues including Sehyo Yune, a former postdoctoral research fellow at MGH Radiology and co-first author of a paper on the work, and Synho Do, senior author, HMS assistant professor of radiology, and director of the lab.

We ensured the data set is of high quality, enabling the AI system to achieve a performance similar to that of radiologists, Lee said.

Second, Lee and colleagues figured out a way to provide a window into an AIs decision-making, cracking open the black box. The system was designed to show a set of reference images most similar to the CT scan it analyzed, allowing a human doctor to review and check the reasoning.

Jonathan Zittrain, Harvards George Bemis Professor of Law and director of the Berkman Klein Center for Internet and Society, said that, done wrong, AI in health care could be analogous to the cancer-causing asbestos that was used for decades in buildings across the U.S., with widespread harmful effects not immediately apparent. Zittrain pointed out that image analysis software, while potentially useful in medicine, is also easily fooled. By changing a few pixels of an image of a cat still clearly a cat to human eyes MIT students prompted Google image software to identify it, with 100 percent certainty, as guacamole. Further, a well-known study by researchers at MIT and Stanford showed that three commercial facial-recognition programs had both gender and skin-type biases.

Ezekiel Emanuel, a professor of medical ethics and health policy at the University of Pennsylvanias Perelman School of Medicine and author of a recent Viewpoint article in the Journal of the American Medical Association, argued that those anticipating an AI-driven health care transformation are likely to be disappointed. Though he acknowledged that AI will likely be a useful tool, he said it wont address the biggest problem: human behavior. Though they know better, people fail to exercise and eat right, and continue to smoke and drink too much. Behavior issues also apply to those working within the health care system, where mistakes are routine.

We need fundamental behavior change on the part of these people. Thats why everyone is frustrated: Behavior change is hard, Emanuel said.

Susan Murphy, professor of statistics and of computer science, agrees and is trying to do something about it. Shes focusing her efforts on AI-driven mobile apps with the aim of reinforcing healthy behaviors for people who are recovering from addiction or dealing with weight issues, diabetes, smoking, or high blood pressure, conditions for which the personal challenge persists day by day, hour by hour.

The sensors included in ordinary smartphones, augmented by data from personal fitness devices such as the ubiquitous Fitbit, have the potential to give a well-designed algorithm ample information to take on the role of a health care angel on your shoulder.

The tricky part, Murphy said, is to truly personalize the reminders. A big part of that, she said, is understanding how and when to nudge not during a meeting, for example, or when youre driving a car, or even when youre already exercising, so as to best support adopting healthy behaviors.

How can we provide support for you in a way that doesnt bother you so much that youre not open to help in the future? Murphy said. What our algorithms do is they watch how responsive you are to a suggestion. If theres a reduction in responsivity, they back off and come back later.

The apps can use sensors on your smartphone to figure out whats going on around you. An app may know youre in a meeting from your calendar, or talking more informally from ambient noise its microphone detects. It can tell from the phones GPS how far you are from a gym or an AA meeting or whether you are driving and so should be left alone.

Trickier still, Murphy said, is how to handle moments when the AI knows more about you than you do. Heart rate sensors and a phones microphone might tell an AI that youre stressed out when your goal is to live more calmly. You, however, are focused on an argument youre having, not its physiological effects and your long-term goals. Does the app send a nudge, given that its equally possible that you would take a calming breath or angrily toss your phone across the room?

Working out such details is difficult, albeit key, Murphy said, in order to design algorithms that are truly helpful, that know you well, but are only as intrusive as is welcome, and that, in the end, help you achieve your goals.

For AI to achieve its promise in health care, algorithms and their designers have to understand the potential pitfalls. To avoid them, Kohane said its critical that AIs are tested under real-world circumstances before wide release.

Similarly, Jha said its important that such systems arent just released and forgotten. They should be reevaluated periodically to ensure theyre functioning as expected, which would allow for faulty AIs to be fixed or halted altogether.

Several experts said that drawing from other disciplines in particular ethics and philosophy may also help.

Programs like Embedded EthiCS at SEAS and the Harvard Philosophy Department, which provides ethics training to the Universitys computer science students, seek to provide those who will write tomorrows algorithms with an ethical and philosophical foundation that will help them recognize bias in society and themselves and teach them how to avoid it in their work.

Disciplines dealing with human behavior sociology, psychology, behavioral economics not to mention experts on policy, government regulation, and computer security, may also offer important insights.

The place were likely to fall down is the way in which recommendations are delivered, Bates said. If theyre not delivered in a robust way, providers will ignore them. Its very important to work with human factor specialists and systems engineers about the way that suggestions are made to patients.

Bringing these fields together to better understand how AIs work once theyre in the wild is the mission of what Parkes sees as a new discipline of machine behavior. Computer scientists and health care experts should seek lessons from sociologists, psychologists, and cognitive behaviorists in answering questions about whether an AI-driven system is working as planned, he said.

How useful was it that the AI system proposed that this medical expert should talk to this other medical expert? Parkes said. Was that intervention followed? Was it a productive conversation? Would they have talked anyway? Is there any way to tell?

Next: A Harvard project asks people to envision how technology will change their lives going forward.

Sign up for daily emails to get the latest Harvardnews.

View post:
Risks and benefits of an AI revolution in medicine - Harvard Gazette

Leading Human Immunology and Infectious Disease Experts to Join UM School of Medicines Institute of Human Virology – Newswise

Newswise Baltimore, MD, November 12, 2020 Robert C. Gallo, MD, the Homer & Martha Gudelsky Distinguished Professor in Medicine at the University of Maryland School of Medicine (UMSOM) and Co-Founder & Director of the UMSOMs Institute of Human Virology (IHV), announced today that a team of leading scientists in human immunology, virology and stem cell biology, led by Lishan Su, PhD joined IHV on October 1 with academic appointments in the UMSOM Department of Pharmacology. As part of the Maryland E-Nnovation Initiative Fund (MEIF) to recruit top research faculty and a donation to IHV from the Charles Gordon Estate, Dr. Su has been named the Charles Gordon Smith Endowed Professor for HIV Research. Dr. Su will also head IHVs Division of Virology, Pathogenesis and Cancer.

The team will include a 12-person Laboratory of Viral Pathogenesis and Immunotherapy with two faculty appointments as well as major public and private sector research funding.

Dr. Gallo made the announcement in conjunction with University of Maryland School of Medicine Dean E. Albert Reece, MD, PhD, MBA and Margaret M. McCarthy PhD, James & Carolyn Frenkil Deans Professor, Chair of the Department of Pharmacology.

Dr. Su is one of the most successful active basic researchers in America, said Dr. Gallo, who is also Co-Founder and Chairman of the International Scientific Leadership Board of the Global Virus Network. His research is groundbreaking, and we are so pleased to have him join IHV and lead our Division of Infectious Agents and Cancer, which under his sound leadership, will flourish.

Dr. McCarthy added:Dr. Sus continuing ground-breaking work in HIV and Hepatitis B will be a huge asset to the Department of Pharmacology. I look forward to working with him on advances that could open the door to new therapeutics.

Dr. Su was a faculty member in the Lineberger Comprehensive Cancer Center and Professor in the Department of Microbiology & Immunology at University of North Carolina-Chapel Hill since 1996. He received his BS degree in Microbiology from Shandong University, his PhD degree in Virology from Harvard University, and did his post-doctoral training in Stem Cell Biology & Immunology at Stanford University. He worked as a senior research scientist at SyStemix/Sandoz (Novartis), focusing on HIV-1 pathogenesis and stem cell-based gene therapy in humanized mice and in patients.

I am excited to continue and expand my research programs at the Institute of Human Virology (IHV), said Dr. Su. I have long been impressed by the Baltimore-DC area's research centers with great basic and clinical research programs. IHV, co-founded and directed by Dr. Robert Gallo, is one of the first research institutes in the U.S. to integrate basic science, population studies and clinical trials to understanding and treating human virus-induced diseases. The Department of Pharmacology, headed by Dr. Margaret McCarthy, in the University of Maryland School of Medicine, has been outstanding in developing novel therapeutics including breast cancer drugs. I look forward to working with my new colleagues at IHV and the Department of Pharmacology, and across the University of Maryland School of Medicine, to expand and translate my research programs to treating human inflammatory diseases including virus infection and cancer.

Dr. Su has extensive research experience in human immunology, virology and stem cell biology. Dr. Su made important contributions to several areas of human immunology and infectious diseases, particularly in studying human immuno-pathology of chronic virus infections. His lab at UNC-Chapel Hill published important findings in identifying novel virological and immunological mechanisms of HIV-1 pathogenesis. Furthermore, his lab established humanized mouse models with both human immune and human liver cells that support HCV or HBV infection, human immune responses and human liver fibrosis. In recent years, Dr. Sus group discovered, and focused on, the pDC-interferon axis in the immuno-pathogenesis and therapy of chronic HIV & HBV infections. The group also started investigation of the pDC-IFN axis in tumor microenvironments and in cancer immune therapy.

Im so pleased to welcome Dr. Su to our faculty. His work advances the mission of the School of Medicine, which is to provide important new knowledge in the area of immunology and chronic disease to discover new approaches for treatments, said Dean Reece, who is also University Executive Vice President for Medical Affairs and the John Z. and Akiko K. Bowers Distinguished Professor. Dr. Sus stellar research capabilities will provide vital opportunities for collaboration across our Institutes and Departments.

About the Institute of Human Virology

Formed in 1996 as a partnership between the State of Maryland, the City of Baltimore, the University System of Maryland and the University of Maryland Medical System, IHV is an institute of the University of Maryland School of Medicine and is home to some of the most globally-recognized and world-renowned experts in all of virology. The IHV combines the disciplines of basic research, epidemiology and clinical research in a concerted effort to speed the discovery of diagnostics and therapeutics for a wide variety of chronic and deadly viral and immune disorders - most notably, HIV the virus that causes AIDS. For more information,www.ihv.organd follow us on Twitter @IHVmaryland.

About the University of Maryland School of Medicine

The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Marylands Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global vision, with research and treatment facilities in more than 30 countries around the world. For more information, visitwww.medschool.umaryland.edu.

Here is the original post:
Leading Human Immunology and Infectious Disease Experts to Join UM School of Medicines Institute of Human Virology - Newswise

Op-ed: Doctor, mentor to Black men, urban renewal champion. Frank Lloyd was that and more – IndyStar

The Indiana Historical Society is collecting documents from Hoosiers ahead of an exhibit and online archive for Indianapolis' bicentennial. Indianapolis Star

With the city celebrating 200 years, the Encyclopedia of Indianapolis assigned profiles of civic leaders, including the late Dr. Frank Lloyd. I recalled him as a prominent doctor, medical researcher and the first African-American president of Methodist Hospital.

He was all that, but also as a quiet and effective civic leader. He joined with a handful of others who transformed Indy from minor- to major-league status.

Born in South Carolina in 1919, Dr. Lloyd graduated from Howard University School of Medicine in Washington, D.C. He served as a Rockefeller Fellow at Columbia Presbyterian Medical Center in New York City, teaching at Columbia University.

Paying respects: Indy's black history makers

Coming to Indianapolis, he established his medical practice, delivering babies and doing research in gynecology and obstetrics.

Dr. Lloyd became one of the first African-American doctors on staff at Methodist Hospital in 1954. He launched a new era as director of medical research in 1963, laying the groundwork for Methodist to become a teaching/research facility in addition to patient care.

In 1981, Dr. Lloyd became the first African-American president of the hospital. Leading the hospital through a major expansion, he hoped Methodist could become an Indiana version of the famous Mayo Clinic in Minnesota.

Photo of Dr. Frank Lloyd, president of Methodist Hospital, 1992(Photo: Rich Miller, Indianapolis Star)

The hospital pioneered the states first adult open-heart surgery in 1965, then the use of an artificial kidney in 1966, and kidney transplants in 1972.

He also taught at medical schools as a visiting professor. In his spare time he joined other civic entrepreneurs who put Indianapolis on the national map beyond the Indianapolis 500 Mile Race and high school basketball.

He was a great physician, said a subsequent Methodist Hospital president, Sam Odle. But he also understood the bigger context of the community the need for African-Americans to have access to information, financial capital and quality education. He was a quiet, reflective man. He didnt wear his smarts on his sleeve.

He was the first chairman of the White River State Park Development Commission, paving the way for the downtown park as an anchor for urban renewal. He also served as co-chair of the Greater Indianapolis Progress Committee, the key organization for the citys revitalization in that era.

He was the key founder of the Midwest National Bank, expanding lending opportunities when traditional banks restricted lending to African-Americans.

He joined with other investors to start radio station WTLC-FM, offering a new African-American perspective in the radio market. He served as president of the Metropolitan Planning Commission during the 1970s, as city fathers were laying the groundwork for the citys growth spurt in subsequent decades.

He also was one of the founding members of 100 Black Men, for mentoring young African-American men.

Sam Jones, then the president of the Indianapolis Urban League, summed him up this way on Lloyds death in 2002: He was a giant among men, not just African-American men, but a giant among men, period.

RussPulliam is associate editor of The Star. Follow him on Twitter at RBPulliam@twitter.com. Email him at Russell.Pulliam@indystar.com.

Read or Share this story: https://www.indystar.com/story/opinion/2020/11/12/op-ed-frank-lloyd-indy-doctor-mentor-black-men-and-more/6231816002/

Read more here:
Op-ed: Doctor, mentor to Black men, urban renewal champion. Frank Lloyd was that and more - IndyStar

Harvard-Wide Task Force ‘Students vs. Pandemics’ Expands into National Initiative | News – Harvard Crimson

Students vs. Pandemics which began as a Harvard-wide task force formed in response to COVID-19 has grown into a national initiative with branches in 10 universities across North America.

Jacob J. Ingber, the national president of Students vs. Pandemics and a graduate student at the Harvard Medical School, said students formed the task force in March to foster a sense of mutual support during the pandemic.

There is a widespread feeling of a loss of agency and a lot of disjointed response efforts across the different Harvard schools, Ingber said. And so we started because we want to give Harvard students and now students across America a community and a space where they could come together and identify the problems that they're going through, and then try to work towards finding a solution.

While the organization initially focused on compiling resources related to COVID-19, SvP has expanded its efforts to include a public speaker series, policy research initiatives, a public health blog, and partnerships with other organizations, Harvard chapter president and Extension School graduate LisaMichelle Pecaro said.

Pecaro explained that through a partnership between SvP and nonprofit Get Us PPE, chapter members sent over 100 shipments of personal protective equipment to Boston area hospitals.

SvP national vice president Grant S. McComb said that chapter members worked with State Sen. Eric P. Lesser 07 to improve the states response to the pandemic.

He was actually able to use a lot of the research we conducted to inform his own policymaking on COVID-19 for his jurisdiction, McComb added.

McComb emphasized that the function of the national branch is to provide the funds, information, resources, and connections necessary for chapters to spearhead their own projects.

Because this organization is really volunteer-run and really volunteer-led, we as a national organization will have minimal initiatives ourselves, but will primarily be supporting our chapters in that way moving forward, he said.

McComb also said SvP plans to broaden its scope to address systemic issues in the public health sector beyond the ongoing COVID-19 pandemic.

We're putting a lot of work into developing this organization, to tackle other problems that will probably come as a result of COVID-19 in the future, but then also other social issues and other health issues that will spring up, but really have nothing to do with COVID, McComb said. We really want this to be an organization that is sustained past this current pandemic.

The SvP team is currently preparing to apply for nonprofit status. Ingber said that the organization has been working with the Harvard Law Schools Transactional Law Clinics during the process.

Growing the initiative in a completely virtual setting has been both a significant challenge and a memorable experience, Ingber said.

Most of us have never met in person and didn't know each other beforehand, he said. Now we find ourselves running a five-hundred person organization together from different states, different parts of the country. And it's been a lot of fun. It's been really cool, but it's definitely challenging.

The rest is here:
Harvard-Wide Task Force 'Students vs. Pandemics' Expands into National Initiative | News - Harvard Crimson

Higher ed’s response to growing demands for medical education | – University Business

Universities need to rethink their approach to healthcare education to get more students in the door and fill the opportunity gap in medical jobs.

No industry has been spared massive disruption from the coronavirus pandemic and resulting rapid digitalization. But for both higher education and healthcare, disruption had already been a way of lifejust on a more gradual scale. The pandemic has further driven down college enrollment numbers that were already on a decade-long decline, leaving many institutions in unprecedented financial distress. Meanwhile, healthcare providers are being pushed to simultaneously deliver higher quality care at a lower cost.

Shiv Gaglani, Osmosis.org

For university leaders, medical education presents an ideal opportunity to address current gaps in enrollment, while also positioning the institution to meet future demands. Not only are we experiencing greater demand for healthcare workers (indeed, six of the fastest 10 growing professions in the U.S. are in healthcare), but the growth of emerging fields like advanced technology, population health, and care coordination means traditional medical schools are not adequately equipped to address current needs.

Expanding healthcare education certificate and degree programs enables universities to get more students in the door today while positioning them for long-term stability through massive transformation. But it involves rethinking the traditional approach.

Since 2002, the Association of American Medical Colleges (AAMC) has reported a 31% growth in enrollment at medical schools. Its no wonderhealthcare is where graduates will find jobs today and tomorrow. The U.S. population is growing older and sicker, with comorbidities like heart disease and diabetes on the rise. At the same time, 33% of working nurses will reach retirement age in the next 8 years. And though the nursing shortage is the most egregious, by 2030, we can expect to see a worldwide shortage of 15 million healthcare workers as the demand for jobs across health systems will likely double.

According to the U.S. Bureau of Labor Statistics, healthcare jobs are expected to grow at a faster pace than any other industryup 14% from 2018 to 2028. These jobs appeal to a diverse population of students, too, offering a variety of entry points, educational requirements and salary expectations. A surgical technician could meet job qualifications in a shorter period of time and still expect to earn $48,000 while a nurse pursuing a RN degree will enter a labor market with a median salary of $73,000, according to the U.S. Department of Labor.

But traditional higher education is simply not equipped to handle the surge of people pursuing degrees in healthcare. Over the last ten years, the number of people applying to medical school has increased by 25%, but there are not enough openings at medical schools to accommodate them. Todays social distancing guidelines in classrooms and residency programs add further strain.

So how can universities adapt to address this opportune gap?

Closing the gap in high-quality medical education is not as simple as launching new degree programs. Just as there are shortages of healthcare workers and medical education spots to train applicants, there are also not enough instructors to meet the demand. And with expansive real estate footprints becoming burdensome when competing with hybrid and online campuses, universities must get creative to maximize their human and real estate capital. The key is to integrate traditional and digital learning techniques.

Digital tools like educational videos and experiential recordings can supplement an instructors knowledge as well as spotlight the latest advancesno matter where they occur. Additionally, as emerging fields grow in popularity, supplemental digital tools provide universities with greater flexibility to apply content to various specialties and learning paths. And considering the speed of technological advancements, relying solely on traditional in-person instruction sets students and institutions behind.

Given that not all healthcare education can be done virtually, its important that there be physical spaces where trainees can meet standardized patients as well as practice on simulated cases and mannequins. As traditional college buildings empty, many of these spaces can be repurposed to provide healthcare training and potentially even basic healthcare to the communities they serve.

Digital content also gives students greater control over their education, enabling them to more extensively pursue topics that interest them the most. Plus, as more people pursue their education while working, for example, a registered nurse studying to become a nurse practitioner, the demand for flexibility in content delivery will only increase.

On-demand content delivery is here to stay and the need for additional medical education will only continue to grow. Combining these two trends presents an ideal opportunity for universities seeking new ways to increase enrollment and strengthen their foundation for the future.

Shiv Gaglani is the co-founder and chief executive officer of Osmosis.org, a health education platform with an audience of current and future clinicians as well as their patients and family members. Gaglanis primary passion is developing innovative and scalable solutions in the fields of healthcare and education. To this end he curated the Smartphone Physical, which debuted at TEDMED, and the Patient Promise, a movement to improve clinician-patient relationship through partnership in pursuing healthy lifestyle behaviors.

More here:
Higher ed's response to growing demands for medical education | - University Business

3 UCSF faculty named to Biden-Harris transition COVID-19 advisory board – University of California

President-elect Joe Biden and Vice President-elect Kamala Harris haveannounced the establishment of a coronavirus advisory board, a panel of public health and scientific experts that will include three UCSF faculty members.

The Advisory Board will help guide planning for the president-elects federal response to the pandemic. The experts will consult with state and local officials to determine the public health and economic steps necessary to get the virus under control, to address ongoing racial and ethnic disparities, and to reopen our schools and businesses safely.

David A. Kessler, M.D., J.D., professor of pediatrics, and of epidemiology and biostatistics, will co-chair the Transition COVID-19 Advisory Board. Also joining the 13-member board areEric Goosby, M.D., professor of medicine, andRobert M. Rodriguez, M.D., professor of emergency medicine.

Dealing with the coronavirus pandemic is one of the most important battles our administration will face, and I will be informed by science and by experts, Biden said in a statement. The Advisory Board will help shape my approach to managing the surge in reported infections; ensuring vaccines are safe, effective, and distributed efficiently, equitably, and free; and protecting at-risk populations.

Kessler served as commissioner of the U.S. Food and Drug Administration under the administrations of Presidents George H.W. Bush and Bill Clinton. He later served as dean of the UCSF School of Medicine and vice chancellor at UCSF from 2003 to 2007.

Goosby is an internationally recognized expert on infectious diseases who served in the administrations of Presidents Clinton and Barack Obama. In the Clinton administration, Goosby served as the interim director of the White Houses Office of National AIDS Policy. Under President Obama, he was appointed Ambassador-at-Large and implemented the U.S. Presidents Emergency Plan for AIDS Relief (PEPFAR). After serving as U.S. Global AIDS Coordinator, he was the UN Special Envoy for Tuberculosis until 2019.

Rodriguez works in the Emergency Department of Zuckerberg San Francisco General Hospital and Trauma Center and in the Intensive Care Unit at Highland Hospital in Oakland. He has led national research teams examining a range of topics in medicine, including the impact of the COVID-19 pandemic on the mental health of frontline providers.

I wish Drs. Kessler, Goosby and Rodriguez the best as they assume these critical leadership roles, said UCSF ChancellorSam Hawgood, MBBS, in aletter to the UCSF community. They represent the extraordinary and relentless dedication the UCSF community has shown in meeting the challenge of the coronavirus across our patient care, research, and education efforts. Our public health mission has never been clearer nor pursued with greater determination.

UCSF looks forward to working with President-elect Bidens administration, he said. We remain committed as ever to our partnership with public health officials at the national, state, and local levels.

The full Transition COVID-19 Advisory Board includes:

View post:
3 UCSF faculty named to Biden-Harris transition COVID-19 advisory board - University of California

MOT Charter student Makayla Boyd picked for Congress of Future Medical Leaders – Middletown Transcript

Amanda Parrish|Middletown Transcript

Headlines November 12, 2020

Here are some of the top stories we're following for Thursday, November 12, 2020.

This Middletown teen is getting a jump on exploring a career in the medical field.

Makayla Boyd, a sophomore at MOT Charter High School, will be a delegate to the Congress of Future Medical Leaders Nov. 21-22.

The congress is an honors-only program for high school students who want to become physicians or go into medical research fields, according to a press release. The event is put on by the National Academy of Future Physicians with the goal to motivate top students from across the country to enter the medical field.

During the two-day Congress, Boyd will join students from across the country and hear Nobel Laureates and National Medal of Science Winners talk about leading medical research; be given medical school advice; and hear stories from patients who are living medical miracles.

This is a crucial time in America when we need more doctors and medical scientists who are even better prepared for a future that is changing exponentially. Focused, bright and determined students like Makayla Boyd are our future and she deserves all the mentoring and guidance we can give her, the press release said.

Boyd was nominated to represent Delaware based on her academic achievement, leadership potential and determination to enter the field of medicine.

More: Free COVID testing at Middletown High every Wednesday in November

Here is the original post:
MOT Charter student Makayla Boyd picked for Congress of Future Medical Leaders - Middletown Transcript

Yale Internal Medicine Partners with Two Federally Qualified Health Centers in Innovative New Care Consortium < Internal Medicine – Yale News

By Saphia Suarez

Last Monday, faculty members from the Yale Section of General Internal Medicine helped open the doors of the New Haven Primary Care Consortium, beginning an innovative journey of collaborative medicine with the goal of revolutionizing primary care in the New Haven area.

The NHPCC is located at 150 Sargent Drive in Long Wharf, New Haven and is a partnership of Yale New Haven Hospital, Cornell Scott-Hill Health Center, and Fair Haven Community Health Center that will have critical input and leadership from Yale School of Medicine faculty.

This collaboration is unusual, says Bradley Richards, MD, assistant professor of medicine (general medicine) and assistant medical director for the NHPCCs Cornell Scott-Hill Health Center Adult Medicine Practice.

It is unusual to have two Federally Qualified Health Centers (FQHCs) under the same roof, says Richards, referring to the Cornell Scott-Hill and Fair Haven Community Health Centers. Thats the unique nature of what were doing here, where theres a lot of collaboration.

Unusual though it may be, discussions of this collaboration have been happening on and off for at least 30 years, says Patrick OConnor, MD, MPH, MACP, Dan Adams and Amanda Adams Professor of General Medicine and chief of General Internal Medicine.

The idea has been out there but it didnt gain traction until about three years ago, says OConnor.

Now that it has, the excitement across the department is palpable.

This is a great opportunity for us to work closely with our colleagues in the community, says OConnor. And undoubtedly it will be a two-way learning process. This unique partnership will combine the expertise of community and academic physicians and other health care professionals to the benefit of our patients and community more broadly.

For Brita Roy, MD, MPH, MHS, assistant professor of medicine (general medicine) and director of Population Health for Yale Medicine, the excitement around this collaboration lies in the opportunity to improve population health.

The hope is that with all of these clinics merged together serving the lower income population in New Haven, well be able to really collaborate and coordinate to develop robust population health systems to better support our most vulnerable, says Roy.

She names the expansive data and resources from the networks of these three care providers as key to co-designing programs to improve systemsand, therefore, health outcomes.

OConnor agreed. The opportunity for us to leverage this collaboration and think creatively about building highly innovative approaches to population health is very exciting.

John Moriarty, MD, FACP, associate professor of medicine (general medicine) and program director for the Primary Care Internal Medicine Residency Program, is particularly excited about what this new consortium will mean for his residents.

Education in this environment will change, says Moriarty. One of the more effective ways to educate residents and students about primary care is to have a team-based approach to education, and understanding that high functioning primary care teams are made up of much more than the physician. Theres the pharmacist, the nurse, the medical assistant, etcetera. You need everyone working at the highest level to optimize care plans for patients. The NHPCC gives residents the opportunity to look at true inter-professional care at a high level.

One new aspect of that inter-professional care at the NHPCC is an integrated behavioral health team. This team includes psychiatrists, psychologists, and licensed clinical social workers who will now work side by side.

In the past we've struggled to get patients the behavioral mental health care they need when they needed it, says Daniel Tobin, MD, FACP, associate professor and medical director of Primary Care alongside Laura Whitman, assistant professor of medicine (general medicine). So having access to an integrated behavioral health team is a significant enhancement. Theyre right next door, so if we have a patient who needs to see someone for an urgent behavioral health issue, we can send them right over.

And, says Moriarty, that integrated behavioral health will teach residents how to effectively care for patients, thereby improving the next generation of physicians in primary care.

So far, the response from patients has been a positive one.

I have seen quite a few patients in the new space already, says Tobin. I think everyones really excited, the space is beautiful, the physical plant is just a significant upgrade from what were used to, so everyones impressed.

Looking forward, OConnor is focused on creating a seamless patient transition from outpatient, inpatient, and community health care.

The transmittal of information in large medical centers like ours can be fragmented at times, says OConnor.

We want to build comprehensive teams who will assure that patients transition between the clinic, and the hospital, and the community with the goal of achieving high quality and cost effective care for the benefit of all patients and their families.

OConnor says he and his team are already beginning to design a more robust approach to seamless care as they simultaneously settle into the new NHPCC space and explore how this collaboration will elevate the collective care the consortium is able to provide to the New Haven community.

The Department of Internal Medicine at Yale is among the nation's premier departments, bringing together an elite cadre of clinicians, investigators and educators in one of the world's top medical schools. To learn more, visit Internal Medicine.

Read more:
Yale Internal Medicine Partners with Two Federally Qualified Health Centers in Innovative New Care Consortium < Internal Medicine - Yale News

Neurologists test novel compound for lung and brain injury in severe COVID-19 patients – Newswise

Newswise Neurologists are researching whether a novel immunomodulatory treatment, OP-101, can dampen lung and brain injury in hospitalized COVID-19 patients through a clinical trial at The University of Texas Health Science Center at Houston (UTHealth).

OP-101 is an investigational compound developed byAshvattha Therapeuticsto selectively attack the proinflammatory macrophages and microglia, which are the immune cells responsible for hyperinflammation, lung injury, and multi-organ failure caused by infections.

We see this type of hyperinflammation in a number of neurological disorders, including Parkinsons and Alzheimers disease, saidAaron Gusdon, MD, an assistant professor in the Vivian L. Smith Department of Neurosurgery at McGovern Medical School at UTHealth and principal investigator of the Houston site of the study. Now were seeing the same activation of the innate immune system in COVID-19 patients that drives production of proinflammatory cytokines, which can contribute to patients becoming rapidly critically ill. OP-101 has shown to robustly suppress hyperinflammation in a number of different disorders, so were investigating if this targeted approach can help patients with severe cases of COVID-19 as well.

Unlike single agent approaches, like antibodies, that address only one pathway, the treatment is intended to seek out and selectively shut down cells that are proinflammatory and restore the macrophages to a normal state.

The hope is that since it only targets the activated component of the innate immune system, it will have fewer side effects and less risk of a concurrent infection compared with some steroids and antibodies that broadly suppresses the whole immune system, said Gusdon, a neurologist with UTHealth Neurosciences.

In COVID-19 patients, we know the lungs and sometimes the brain become severely inflamed, saidLouise McCullough, MD, PhD,professor and Roy M. And Phyllis Gough Huffington Distinguished Chair in the Department of Neurology at McGovern Medical School and co-investigator of the OP-101 Houston site. Were seeing that trend play out in the long-hauler patients, as the inflammation can lead to long-term symptoms like confusion, fatigue, and depression. Were interested to see if selectively targeting the activated cells in the lungs, blood, and brain, can help dampen the cytokine storm and possibly prevent the consequences of lung and brain injury for these patients down the road. McCullough is also the co-director of UTHealth Neurosciences and chief of the Neurology Service at Memorial Hermann-Texas Medical Center.

McCullough is treating patients with neurological long-hauler symptoms at theUT Physicians Post-COVID-19 clinic, which is part of the UTHealth COVID-19 Center of Excellence and was the first post-coronavirus clinic in Houston.

The Phase II trial, called PRANA, is taking place at Memorial Hermann-Southwest and Memorial Hermann-Memorial City, along with several other sites across the country.

Were proud to offer some of the most innovative care not only to patients in the Texas Medical Center, but in surrounding sites as well, McCullough said.

At the Houston site, seven patients have been enrolled so far, and researchers are seeking two to four more. The national study will enroll approximately 24 patients.

Patients will be randomized to one infusion of OP-101 or placebo, in addition to standard-of-care therapy. Researchers will evaluate whether the treatment reduced inflammation, improved fever and oxygenation, and reduced the number of days without a ventilator, or time in the intensive care unit.

This research builds on a strong foundation of COVID-19 neurological research that McCullough andH. Alex Choi, MD, have built since the start of the pandemic.

Were a good fit to be on the front lines of coronavirus research because in addition to being neurologists, were also intensivists, said Choi, associate professor and vice chair ad interim for neuro critical care with McGovern Medical School, and a neurologist at UTHealth Neurosciences. Were interested in how systemic changes like sepsis and respiratory failure impact long-term cognitive functioning. We have established a prospective longitudinal study of COVID patients to understand how severe systemic inflammation can cause brain injury and long-term symptoms. We need to be part of the solution and understand how coronavirus affects patients long-term. Choi is also the director of neurocritical care for Memorial Hermann Health System and director of the neuroscience intensive care unit at Memorial Hermann-TMC.

For more information about the PRANA Phase II study, call 713-500-UTHN (8846) or visitclinicaltrials.gov.

Media inquiries: 713-500-3030

Go here to see the original:
Neurologists test novel compound for lung and brain injury in severe COVID-19 patients - Newswise

New Targeted Approach Could Prevent Toxicities Associated with Neurological Gene Therapies – BioSpace

Researchers from Penn Medicine have developed a new targeted approach that modifies viral vectors and inhibits toxicities in the sensory neurons of dorsal root ganglia (DRG) that commonly occur following the use of gene therapy for neurological diseases.

This strategy will likely have several important research and clinical implications, as investigators in the field have worked tirelessly for years to develop safer and more effective gene therapies for neurological disorders. We believe that this new approach could improve safety in gene therapy universally, said lead author Juliette Hordeaux, DVM, Ph.D., senior director of Translational Research in Penns Gene Therapy Program, in a statement.

Many gene therapies use viral vectors, but these vectors can have adverse neurological effects. While these toxicities have not yet been observed in humans, nonhuman primate studies using adeno-associated viral (AAV) vectors to deliver corrected genes via the spinal cord fluid have shown issues of axonal degeneration in spinal cord and peripheral nerve tracts. In these studies, the cause of the issues led back to the DRG, comprising a cluster of neural cells found on the outside of the spinal cord that are responsible for delivering sensory messages.

In a recent paper published in Science Translational Medicine, Dr. Hordeaux and colleagues found a way of modifying these vectors so they ultimately avoid these dangerous side effects. They first found that the toxicities appear to come from overexpression of a transgene in cells in the DRG.

The researchers altered a transgene with a microRNA target that was designed to reduce transgene expression levels in the DRG. Ultimately, this modification eliminated over 80% of the transgene expression and resulted in drastic toxicity reduction in the studied primates

We believe it is a safe, straightforward way to ameliorate the safety of AAV therapy for the central nervous system, said Hordeaux about the studied modification. This approach could be used to design other gene therapy vectors to repress transgene expression in the cell types that are affected by the toxicity and not others, which is critical, because you need the expression everywhere else to effectively treat the disorder.

Senior author of the paper was gene transfer expert James M. Wilson, MD, Ph.D., professor of Medicine and Pediatrics in Penns Perelman School of Medicine. Dr. Wilson, who left Solid Biosciences two years ago. Dr. Wilson has been discussing the potential adverse neurological effects of AAV vectors for several years.

Drs. Hordeaux and Wilson injected vectors with and without a microRNA target miRNA183 in mice and primates in the new study. The administration of unaltered AAV vectors led to robust delivery of the gene into target tissue as well as toxicities in DRG neurons. These effects occurred without impacting transduction in elsewhere in the brain, according to histological analyses conducted up to 90 days later.

The authors of the study suggest the toxicity of DRGs likely occur in a gene therapy relying on high vector doses or direct vector delivery into the fluid of the spinal cord. We were concerned about the DRG pathology that was observed in most of our nonhuman primate studies, noted Wilson. This modified vector shows great promise to reduce DRG toxicity and should facilitate the development of safer AAV-based gene therapies for many central nervous system diseases.

Read more from the original source:
New Targeted Approach Could Prevent Toxicities Associated with Neurological Gene Therapies - BioSpace

Neurological Symptoms Mixed with COVID-19 May Mean Double the Worse Outcomes – DocWire News

Its been documented that patients with preexisting conditions may have greater risks when it comes to COVID-19. Now, according to research, patients with neurological symptoms and COVID-19 may be at risk for not only more severe COVID-19 symptomsbut exacerbated neurological symptoms as well.

The authors of the study queried the MEDLINE and medRxiv databases for relevant studies that reported on patients with preexisting neurological disorders and COVID-19 that reported the severity of the latter and/or changes in symptoms of the former. Severe COVID-19 was defined as having severe/critical pneumonia or admission to the intensive care unit.

Of 1,702 total studies identified (866 from MEDLINE, 836 from medRxiv), 26 studies encompassing 2,278 total patients were included in the final analysis. The disorders represented in the studies included cerebrovascular disease, Parkinsons disease, multiple sclerosis and related disorders, aquaporin-4 (AQP-4)-positive neuromyelitis optica spectrum disorder (NMOSD), dementia and cognitive disorder, epilepsy, spinal cord injury, systemic atrophy, myelopathy, intracranial mass, and unspecified disorders.

Not every study discussed both outcomes (the exacerbation of neurological symptoms and COVID-19 severity), so patients were stratified by those with preexisting neurological disorders and COVID-19 for where exacerbation of neurological symptoms was available (n=232) and where the severe COVID-19 course was available (n=2,618).

Among the patients whose neurological symptoms exacerbation was reported, 74 (31.9%) presented exacerbated preexisting neurological symptoms. This was observed in more than half of the patients with dementia (n=55/92; 59.5%) and Parkinsons disease (n=10/17; 58.8%).

Among the patients whose COVID-19 severity course was reported, 478 (22%) presented worsening COVID-19 severity. This was observed in about one-fifth of patients with cerebrovascular disease (n=86/445; 19.3%) and dementia (n=70/316; 22.2%) and two in five patients with multiple sclerosis (n=28/71; 39.4%); it was also seen in patients Parkinsons disease (25/214; 11.7%), epilepsy (10/98; 10.2%), spinal cord injury (5/7; 71.1%), and unspecified neurological disorders (254/1011; 25%).

The study was published in Clinical Neurology and Neurosurgery.

Clinicians should be aware of the risks of an exacerbation of neurological symptoms and an increase in COVID-19 severity in patients with preexisting neurological diseases, and should focus on the prevention and early care of COVID-19, the researchers concluded.

Read this article:
Neurological Symptoms Mixed with COVID-19 May Mean Double the Worse Outcomes - DocWire News

Neurovascular Embolization Devices (Neurology) Market: Web Devices Emerge as Less-invasive Alternative for Neurovascular Embolization Treatment – The…

Transparency Market Research (TMR) has published a new report on the neurovascular embolization devices (neurology) market for the forecast period of 20192027. According to the report, the global neurovascular embolization devices (neurology) market was valued at ~US$ 1.2 Bn in 2018, and is projected to expand at a CAGR of ~3% from 2019 to 2027.

Neurovascular Embolization Devices (Neurology) Market: Overview

Request Brochure of Report https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73906

Rise in Prevalence of Stroke to Drive Neurovascular Embolization Devices (Neurology) Market

Embolization Coils Dominated Neurovascular Embolization Devices (Neurology) Market

Request for Analysis of COVID-19 Impact on of Neurovascular Embolization Devices (Neurology) Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73906

Hemorrhagic Stroke Solutions Held Leading Share of Neurovascular Embolization Devices (Neurology) Market

Brain Aneurysms Indication to Lead Neurovascular Embolization Devices (Neurology) Market

Hospitals End User to be Prominent

Buy Neurovascular Embolization Devices (Neurology) Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=73906&ltype=S

North America to Dominate Market; Asia Pacific to Offer Significant Growth Opportunities

Growth Strategies of Key Players

More Trending Reports by Transparency Market Research

Laboratory Equipment Services Market: https://www.biospace.com/article/laboratory-equipment-services-market-exclusive-study-report-on-the-current-scenario-of-industry/

Read our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/

See the article here:
Neurovascular Embolization Devices (Neurology) Market: Web Devices Emerge as Less-invasive Alternative for Neurovascular Embolization Treatment - The...

Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review -…

This article was originally published here

Clin Neurol Neurosurg. 2020 Nov 1:106349. doi: 10.1016/j.clineuro.2020.106349. Online ahead of print.

ABSTRACT

BACKGROUND: Patients with chronic diseases likely develop severe 2019 coronavirus disease (COVID-19). However, little is known about the effects of COVID-19 on patients with neurological disorders. We conducted a systematic review to evaluate the severity of COVID-19 and its effect on neurological symptoms in patients with preexisting neurological disorder and COVID-19.

METHODS: We searched the MEDLINE (PubMed) and medRxiv databases for reports of patients with both preexisting neurological disorders and COVID-19. Studies reporting data on changes in the symptoms of preexisting neurological disorders and/or the severity of COVID-19 were included.

RESULTS: Twenty-six articles with 2278 patients with preexisting neurological disorder and COVID-19 were identified. Of 232 patients, 74 (31.9 %) showed exacerbation of preexisting neurological symptoms of dementia (55/92; 59.5 %), Parkinsons disease (10/17; 58.8 %), epilepsy (1/1; 100 %), and unspecified neurological disorders (8/106; 7.5 %). Of 2168 patients, 478 (22.0 %) showed severe COVID-19 course. These included patients with cerebrovascular disease (86/445; 19.3 %), dementia (70/316; 22.2 %), Parkinsons disease (25/214; 11.7 %), multiple sclerosis (28/71; 39.4 %), spinal cord injury (5/7; 71.4 %), epilepsy (10/98; 10.2 %) and unspecified neurological disorders (254/1011; 25 %).

CONCLUSIONS: Patients with preexisting neurological disorders and COVID-19 may develop exacerbation of neurological symptoms and severe COVID-19. Clinicians should be aware of the risk of symptom exacerbation and severe COVID-19 in patients with preexisting neurological disease and should focus on the prevention and early care of COVID-19.

PMID:33172719 | DOI:10.1016/j.clineuro.2020.106349

The rest is here:
Exacerbation of neurological symptoms and COVID-19 severity in patients with preexisting neurological disorders and COVID-19: A systematic review -...

Interventional Neurology Device Market: Technological Advancement & Growth Analysis with Forecast to 2025 – Eurowire

Overview Of Interventional Neurology Device Industry 2020-2025:

This has brought along several changes in This report also covers the impact of COVID-19 on the global market.

The Interventional Neurology Device Market analysis summary by Reports Insights is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

Interventional Neurology Device Market competition by top manufacturers as follow:MedtronicJohnson and JohnsonTerumo CorporationPenumbra, Inc.Merit Medical Systems, IncW.L. Gore & AssociatesMicroport Scientific CorporationMedikit Co., Ltd.Stryker

Get a Sample PDF copy of the report @ https://reportsinsights.com/sample/176258

The global Interventional Neurology Device market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

The Type Coverage in the Market are: Embolization & coilingNeurothrombectomy Devices

Market Segment by Applications, covers:Treatment of Cerebral AneurysmsTreatment of Cerebral VasospasmVertebroplasty

Market segment by Regions/Countries, this report coversNorth AmericaEuropeChinaRest of Asia PacificCentral & South AmericaMiddle East & Africa

Major factors covered in the report:

To get this report at a profitable rate.: https://reportsinsights.com/discount/176258

The analysis objectives of the report are:

Our report offers:

Market share assessments for the regional and country level segments. Market share analysis of the top industry players. Strategic recommendations for the new entrants. Market forecasts for a minimum of 9 years of all the mentioned segments, sub segments and the regional markets. Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations). Strategic recommendations in key business segments based on the market estimations. Competitive landscaping mapping the key common trends. Company profiling with detailed strategies, financials, and recent developments. Supply chain trends mapping the latest technological advancements.

Access full Report Description, TOC, Table of Figure, Chart, etc. @ https://reportsinsights.com/industry-forecast/Interventional-Neurology-Device-Market-176258

About US:

Reports Insights is the leading research industry that offers contextual and data-centric research services to its customers across the globe. The firm assists its clients to strategize business policies and accomplish sustainable growth in their respective market domain. The industry provides consulting services, syndicated research reports, and customized research reports.

Contact US:

:(US) +1-214-272-0234

:(APAC) +91-7972263819

Email:[emailprotected]

Sales:[emailprotected]

Read this article:
Interventional Neurology Device Market: Technological Advancement & Growth Analysis with Forecast to 2025 - Eurowire

Global Minimally Invasive Neurology Device Market Is Anticipated To Witness Major Revenue Uplift During The Forecast Period 2020-2026| Reportspedia -…

Reportspedia has added a new report, titled: Global Minimally Invasive Neurology Device Market Research Report 2020

As per the findings of the report, the demand in the global Minimally Invasive Neurology Device market will increment at a notable CAGR during the forecast period of 2020 to 2026

Global Minimally Invasive Neurology Device Market Report helps the readers to maximize their profits and business making ventures by gaining complete insights of Minimally Invasive Neurology Device Industry. The latest developments and growth opportunities in Minimally Invasive Neurology Device market are covered. Development trends, revenue analysis, Minimally Invasive Neurology Device market share and market dynamics are presented to optimize the business. The vital Minimally Invasive Neurology Device insights, opportunities in existing and emerging segments are explained. An in-depth analysis on the present state of Minimally Invasive Neurology Device, progressive future trends, and comprehensive analysis based on Minimally Invasive Neurology Device type, application, players and regions are covered. The report thoroughly analyzes the Minimally Invasive Neurology Device competitors, SWOT analysis, industry chain structure and production process view.

Basically the Minimally Invasive Neurology Device market is segmented by types, application and region. For each of these segments, the report provides revenue in terms of million USD, growth rate, comparison of demand and future prospects between products and application, and revenue generated from sales.

Get A Free Sample Copy Here:

https://www.reportspedia.com/report/life-sciences/global-minimally-invasive-neurology-device-market-report-2019,-competitive-landscape,-trends-and-opportunities/28292#request_sample

To represent an elaborated competitive landscape, the report profiles some of the key companies currently holding a position of strength in the global Minimally Invasive Neurology Device market

Key players

Mayo Clinic CompanySwedish Neuroscience Institute CompanyNICO Corporation CompanyXylos CorporationMedtronic plcTel Aviv Sourasky Medical Center CompanyHadassah Medical Center CompanyReplication Medical, Inc.StereoTools SAOptiscan Imaging Limited Company

Market Segmentation

By Type:

Type 1Type 2Type 3

By Application:

Application 1Application 2Application 3

Areas Of Interest Of Minimally Invasive Neurology Device Report

1. Validated primary and secondary research methodology and data sources are implied to collect key Minimally Invasive Neurology Device information like market size, trends, revenue analysis.

2. Key Minimally Invasive Neurology Device insights like competitive industry scenario, gross margin analysis, price structures, and growth prospects are evaluated.

3. Pinpoint study on market trends, value, production, and marketing strategies adopted by top Minimally Invasive Neurology Device players are explained in this report.

4. The main objective of this report is to analyze the opportunities, threats and Minimally Invasive Neurology Device market drivers.

5. A key analysis of Minimally Invasive Neurology Device development scenario, investment feasibility, major segments is conducted.

Inquire Before Buying Or Ask For Custom Requirement:

https://www.reportspedia.com/report/life-sciences/global-minimally-invasive-neurology-device-market-report-2019,-competitive-landscape,-trends-and-opportunities/28292#inquiry_before_buying

Key Highlights of Minimally Invasive Neurology Device Industry Report

Key Highlights Of Table Of Content:

Minimally Invasive Neurology Device Introduction and Market Overview

Global Minimally Invasive Neurology Device Market Size Analysis By Type, Application, By Region(2014-2020)

Industry Chain Analysis

Global Minimally Invasive Neurology Device Value, Production, Growth Rate and Market Share by Type (2014-2020)

Global Minimally Invasive Neurology Device Consumption, Growth Rate and Market Share by Application (2014-2020)

To know More Details About Minimally Invasive Neurology Device Market research Report @:

https://www.reportspedia.com/report/life-sciences/global-minimally-invasive-neurology-device-market-report-2019,-competitive-landscape,-trends-and-opportunities/28292#table_of_contents

Contact Us:

Name: Alex White

Phone: US: +1(806)4400782/ UK: +44 33 3303 4979

Email: [emailprotected]

Read this article:
Global Minimally Invasive Neurology Device Market Is Anticipated To Witness Major Revenue Uplift During The Forecast Period 2020-2026| Reportspedia -...

Brain Monitoring Devices Market: High incidence of neurological disorders to drive the market – BioSpace

Global Brain Monitoring Devices Market: Overview

The National Institute of Mental Health in the US states that every 1 in 4 adults suffers from a brain disorder every year. It further asserts that at least 6% suffer from serious disabilities due to severe brain damage. This alarming statistic goes to show the dire need for brain monitoring devices in the global healthcare industry today. Research shows that brain monitoring devices will be in significant demand in critical care units due to a high incidence of accidents pertaining to brain trauma and injuries in recent past. The market offers a wide range of devices to treat the abnormal brain activities and restore its functioning, depending on the case.

The global brain monitoring market has been analyzed by researchers at Transparency Market Research using foolproof research methodologies. The document has been collaborated using information from various journals, interviews, whitepapers, conferences, and magazines. The report also includes an assessment of the competitive landscape present in the global brain monitoring devices market. It offers a thorough understanding of the overall market dynamics and maps a plausible trajectory for the market.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1322

Global Brain Monitoring Devices Market: Drivers and Trends

The high incidence of neurological disorders in recent years due to changing lifestyles, rising stress levels, and radical changes in the social environments have cumulatively augmented the demand for brain monitoring devices market. Today, these devices are used for understanding the conditions of patients suffering from Alzheimers disease, epilepsy, multiple sclerosis, and brain tumors amongst others. Thus, the increasing number of patients suffering from these conditions are expected to serve as a strong market driver for the global brain monitoring devices market.

The various brain monitoring devices available in the global market are intracranial pressure monitors, magnetoencephalography, electroencephalograph, cerebral oximeters, and transcranial doppler. These devices track brain function such as the velocity of blood flow in the veins and arteries in case of epilepsy, pressure surrounding the brain, electrical and neural activity, brain death, and traumatic brain injury. The market is also growing due to the rising number of post-surgical cerebrovascular accidents. These incidences have led to an augmented demand for automated brain monitoring devices in clinics and hospitals to understand the impact of anesthesia and sedatives.

Analysts note that the improvement in functionality of these devices, their user-friendliness, and affordability along with technological advancements will encourage the growth of the global market in the coming years.

Request for Analysis of COVID-19 Impact on Brain Monitoring Devices Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=1322

Global Brain Monitoring Devices Market: Geographical Outlook

On the basis of region, the global brain monitoring devices market is segmented into Asia Pacific, North America, Europe, and Rest of the World. Analysts predict that North America is expected to lead the global market as the region has a strong healthcare infrastructure. The high adoption of technology and high penetration of mobile device have given this market an edge over other regions. The brain monitoring devices market in North America is also being encouraged by the supportive regulatory framework and affordable healthcare plans. The significant rise in the geriatric population has also made its contribution to the rise of the brain monitoring devices market in North America. Research indicates that rising patient awareness about benefits of brain monitoring devices to treat disorders such as sleep apnea, Alzheimers disease, and epilepsy amongst others will also propel the regional market.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=1322

Key Players Mentioned in the Report

Some of the leading players operating in the global brain monitoring devices market are Advanced Brain Monitoring, Inc., Covidien PLC, Natus Medical, Inc., and Nihon Kohden Corporation.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Pre Book Brain Monitoring Devices Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=1322&ltype=S

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

Read more information here:

https://www.transparencymarketresearch.com/brain-monitoring-devices.html

The following regional segments are covered comprehensively:

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Mr. Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

Read the original:
Brain Monitoring Devices Market: High incidence of neurological disorders to drive the market - BioSpace

Global Interventional Neurology Device Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 -…

MarketsandResearch.biz has published a new report titled Global Interventional Neurology Device Market 2020 by Manufacturers, Type and Application, Forecast to 2025 that aims to define the market size of different segments in previous years and to forecast the values to the next five years. The report entails a comprehensive database on market estimation based on historical data analysis. The report emphasizes knowledge-based information on both qualify qualitative and quantitative aspects of the industry. It covers the new players entering the global Interventional Neurology Device market. It focuses on primary and secondary drivers, market share, leading segments, and regional analysis. Then the report demonstrates detailed information about the crucial aspects such as drivers and restraining factors which will show the future growth of the market.

The most recent improvements and new industrial explanations are revealed in the report. Report analysts analyze the key elements such as demand, growth rate, cost, capacity utilization, import, margin, and production of the global market players. The report further focuses on global major leading industry players of the global Interventional Neurology Device market providing information such as company profiles, product picture, and specification, production, price, cost, revenue, and contact information. Details of different sections and sub-sections of the global market on the basis of topographical regions have been given. In terms of a global perspective, this report represents the overall market size by analyzing historical data and future prospects.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/74333

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Primitive vendors included in the market are: Medtronic, Medikit Co., Ltd., Penumbra, Inc., Johnson and Johnson, Microport Scientific Corporation, Terumo Corporation, W.L. Gore & Associates, Merit Medical Systems, Inc, Stryker

Market Scenario:

The report also highlights on its applications, types, deployments, components, developments of this market. It scrutinizes a number of potential growth factors, risks, restraints, challenges, market developments, opportunities. The development of the industry is assessed with information on the current status of the global Interventional Neurology Device industry in various regions. The report also covers the recent agreements including merger & acquisition, partnership or joint venture, and the latest developments of the manufacturers.

The product types covered in the report include: Embolization & coiling, Neurothrombectomy Devices, etc.

The application types covered in the report include: Treatment of Cerebral Aneurysms, Treatment of Cerebral Vasospasm, Vertebroplasty, etc.

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/74333/global-interventional-neurology-device-market-2020-by-manufacturers-type-and-application-forecast-to-2025

Regional Segmentation:

The global version of this report with a geographical classification such as: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa). The authors of the report have studied the regions having growth potential to help companies plan their future investments. Key regions are assessed, with sales, revenue, market share, and growth rate of Interventional Neurology Device in these regions, from 2020 to 2025. This chapter also studies the regulatory reforms and norms that are expected to impact the global market.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.bizWeb: http://www.marketsandresearch.biz

View post:
Global Interventional Neurology Device Market 2020 | Demand and Scope with Outlook, Business Strategies, Challenges and Forecasts to 2025 -...